Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 97 results for "biotechnology regulatory authority of..."

Lok Sabha passes the The Regional Centre for Biotechnology Bil...

The Lower House of the Parliament passed The Regional Centre for Biotechnology Bill, 2016. The Bill seeks to establish a Regional Centre for Biotechnology, an institution of education, training and research, under the auspices of United Nations ... Press Information Bureau, 1 month ago

1 images for "biotechnology regulatory authority of india b"

Media Nama, 1 week ago

Indian Pharmacovigilance Day 2016 to be observed in Mumbai on July 29

India is emerging as a target destination for procuring support services required for the global pharmaceutical industry, especially in pharmacovigilance. Several steps have been taken by the Indian regulatory authorities recently to strengthen the ...
 PharmaBiz1 week ago

Nurturing the BioTech Start-Up Ecosystem from First Principles

Dr Renu Swarup Managing Director, Biotechnology Industry Research Assistance Council (BIRAC) Dr Renu Swarup , Managing Director of the Biotechnology Industry Research Assistance Council (BIRAC) explains about the succor her organisation is ...
 EHealth Magazine1 month ago
Barchart

Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting

HERTFORDSHIRE, England , PITTSBURGH and BENGALURU, India , June 3, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of data from the HERITAGE study at the 2016 ...
 Barchart3 weeks ago ASCO2016: Mylan-BioCon's Biosimilar Cancer Drug Comparable to Roche's Herceptin  BioSpace2 weeks ago
[x]  

GEOVAX LABS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition And Results of Operations

whether we are successful in developing our products; ? whether we are able to obtain regulatory approvals in the United States and other countries for sale of our products; ? whether we can compete successfully with others in our market; and ...
 Equities.com1 month ago ADVAXIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)  4 Traders2 weeks ago ADVAXIS, INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS  Equities.com2 weeks ago

Monsanto rejects $62B takeover bid from Bayer AG as 'inadequate'

Biotechnology company Monsanto announced Tuesday that it has refused a $62 billion takeover offer from pharmaceutical giant Bayer AG as "incomplete" and "inadequate." Monsanto has been open to a corporate takeover to help resolve some financial ...
 Equities.com1 month ago

Proposed Placing and Amendment to GHIF Bond

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR THE UNITED STATES ...
 MoneyAM2 days ago

Hold the Opportunity at Emerging Markets for High Growth Life Science and Chemical Instrumentation 2016-2024

Life Science and Chemical Instrumentation Market is expected to register a high single-digit CAGR by 2024, Market for Life Science and Chemical Instrumentation is dominated by North America, Asia Pacific. This press release was orginally ...
 Digital Journal5 days ago

Healthcare Analytical Testing Services Market by Type, by End User - Global Forecast to 2021

1 of 4 The Global Healthcare Analytical Testing Services Market is Estimated to Grow at a CAGR of 11.3% From 2016 to 2021, to Reach USD 4.13 Billion by 2021 from USD 2.42 Billion in 2016. FEATURED COMPANIES Anabiotec Envigo Eurofins ...
 Research and Markets1 week ago Global Healthcare Virtual Reality & Augmented Reality Systems Market Assessment & Forecast 2016 - 2020  SlideShare.net4 weeks ago

FDA Grants Soligenix Fast Track Designation for SGX943 for the Treatment of Melioidosis

Treatment for Melioidosis Princeton, NJ May 31, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
 Drugs.com1 week ago Soligenix, Inc. (SNGX: OTCQB) | FDA Grants Soligenix "Fast Track" Designation for SGX943 for the Treatment of Melioidosis  OTC Markets3 weeks ago SOLIGENIX : FDA Grants Soligenix "Fast Track" Designation for SGX943 for the Treatment of Melioidosis  4 Traders3 weeks ago Soligenix Release: FDA Grants Soligenix "Fast Track" Designation For SGX943 For The Treatment Of Melioidosis  BioSpace3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biotechnology regulatory authority of india b
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less